We are a global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies.
Our Unique Position
- World leader in ADC contract development and manufacturing
- World-class facilities in the UK and US, backed by a highly experienced team
- Integrated services from conjugation development to clinical and commercial GMP batch manufacturing and sterile fill/finish
- 98% GMP batch success rate
- ADC Grangemouth Site is successfully audited by US FDA, UK MHRA, Brazil ANVISA, Japan PMDA